fbpx

Now Available: Our 2023 State of Patient Empowerment Report Learn more >>

Late recurrence in breast cancer

Written By:

breast cancer recurrence

In the field of breast cancer care, medical professionals are increasingly moving away from terms such as ‘cured’ or ‘remission.’ The shift in language indicates a sobering reality: for the most common types of breast cancer, the risk of recurrence remains substantial, even beyond the first five years, potentially extending for decades after initial treatment. While this knowledge may be unsettling, you must be informed to advocate for your long-term care and preparedness plan.

About 75% of primary breast tumors have already begun to spread to nearby or distant parts of the body when they are first discovered. These tiny, spread-out cancer cells, known as micrometastases, exist in a ‘sleeping’ state, where their growth is kept in check; however, changes in certain cells and substances around the tumor can ‘wake up’ these sleeping cells, allowing them to grow and spread. Recognizing these dynamics is crucial in advocating for effective follow-up care and monitoring for survivors.

When we talk about breast cancer recurrence, it’s often a shock to many that the disease can return many years after the initial diagnosis and treatment. This phenomenon, known as “late recurrence,” happens after five years and sometimes even after 20 years or more. This is especially true for those with estrogen receptor-positive tumors, where the likelihood of cancer recurring after the first five years is actually higher than in the first five years. Contrary to the common belief that a five-year survival post-treatment equates to a cure, the reality is that the risk of recurrence for hormone-sensitive (estrogen and/or progesterone receptor-positive) breast tumors persists for a lifetime after the initial diagnosis. This remains true even for very small tumors with no node involvement.

The severity of late distant recurrence in breast cancer is critical to discuss with your oncology team. When breast cancer metastasizes, it becomes incurable. Given the gravity of late distant recurrence, researchers are dedicated to finding ways to predict its occurrence. These efforts primarily focus on understanding the biology and genetics of breast cancer tumors. Technology advancements have allowed for sophisticated gene-expression profiling, which helps categorize tumors and predict their behavior over time. Researchers are currently studying the role of circulating tumor cells and DNA in the bloodstream as potential indicators of recurrence. The ultimate goal is to develop a comprehensive model integrating patient-specific factors, tumor characteristics, and genetic markers to predict the risk of late recurrence more accurately. This predictive model would enable personalized treatment plans, improving the long-term outcomes for patients.

Treatment plan choices can significantly impact late recurrences. For instance, chemotherapy plays a vital role in reducing the risk of recurrence in the initial five years but has less effect on the risk of late breast cancer recurrence.

On the other hand, hormonal therapy can be a game-changer. It not only decreases the risk of breast cancer recurrence in the first five years by over a third with tamoxifen (and even more so with aromatase inhibitors), but it also helps reduce the risk of late recurrences. This significant risk reduction is what has led experts to recommend extending hormonal therapy beyond five years for those at a higher risk. In a 2019 study, it was found that patients with luminal A tumors showed considerable benefit from tamoxifen therapy even up to 15 years post-diagnosis. Nonetheless, this decision to prolong therapy must balance the recurrence risk with potential side effects that may arise from continuous treatment, like heart disease and osteoporosis. This underlines the importance of a customized approach to treatment and continuing research to help provide the best care possible for breast cancer patients.

Understanding and navigating the complexities of breast cancer, especially the potential for late recurrence, can be overwhelming. However, you’re not alone. Leveraging advancements in treatments and regular monitoring can make a significant difference, and tools like Outcomes4Me can prove invaluable in the effort to remain informed on all of your options. As new research is released and treatments get approved, Outcomes4Me will provide you with the latest recommendations directly in the app under your treatment plan. We encourage you to check in regularly to stay updated with any potential changes in your treatment approach. Remember, knowledge is power, and maintaining a proactive approach to your healthcare will equip you to face this challenge with confidence and strength.

Related Articles

A breast cancer diagnosis can be an overwhelming experience filled with complex terminology and metrics...
Navigating a breast cancer diagnosis involves confronting a myriad of uncertainties, not least of which...

Breast cancer late recurrence

Risk of breast cancer recurrence